CareDx SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits
AI summary, unreviewedCareDx Q3 2026 Revenue Rises 39% to $139.4 Million, Beats $122.0 Million Consensus; Non-GAAP EPS $0.70 vs $0.26 Expected; 2026 Revenue Guidance Raised to $520-530 Million
Completion of acquisition or disposition of assets · Financial statements and exhibits
Results of operations and financial condition · Regulation FD disclosure · Financial statements and exhibits